Cogent Biosciences (COGT) Other Operating Expenses (2019 - 2020)
Cogent Biosciences' (COGT) quarterly Other Operating Expenses came in at $23000.0 in Q4 2020, up 675.0% year-on-year from $2967.7 in Q1 2020, and down 99.69% on a QoQ basis from $7.5 million in Q3 2020.
Cogent Biosciences (COGT) Other Operating Expenses (2019 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has 2 years of Other Operating Expenses data on file, last reported at $23000.0 in Q4 2020.
- On a quarterly basis, Other Operating Expenses rose 675.0% year-over-year to $23000.0 in Q4 2020; TTM through Sep 2021 was $23000.0, a 99.69% decrease from a year earlier, with the FY2020 full-year figure at $7.5 million, up 9506.41% from the prior year.
- Other Operating Expenses for Q4 2020 stood at $23000.0, down from $7.5 million in the prior quarter.
- Over the last five years, Other Operating Expenses for COGT reached as high as $7.5 million in Q3 2020 and fell as low as -$4000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Cogent Biosciences | 6.45 Bn | 6.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | 7.46 Mn |
| Dec 31, 2019 | -4,000.00 |
| Sep 30, 2019 | 82,000.00 |